Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Iloprost for Bridging to Heart Transplantation in Patients With Pulmonary Hypertension and Left Heart Failure A Randomized, Controlled, Double-blind, Parallel Group, Proof-of-concept Trial

NCT02482402 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.

NCT NCT02482402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02482402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Iloprost for Bridging to Heart Transplantation in Patients With Pulmonary Hypertension and Left Heart Failure A Randomized, Controlled, Double-blind, Parallel Group, Proof-of-concept Trial
Lead sponsor
Heidelberg University
Phase
Phase 2
Overall status
Withdrawn
Start date
February 28, 2015
Completion date
March 17, 2015
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic left ventricular failure, pulmonary hypertension